reviewTop 1% cited
Antiretroviral Therapy for HIV Infection
Drugs · 1998 · Vol. 55(3) · pp. 383–404
Graeme Moyle✉(Chelsea and Westminster Hospital)Brian Gazzard(Chelsea and Westminster Hospital)David A. Cooper(St Vincent's Hospital Sydney)Jos Gatell(Hospital Clínic de Barcelona)
HIV/AIDS drug development and treatmentHIV Research and TreatmentHIV/AIDS Research and InterventionsMedicineTolerabilityCombination therapyRegimenSalvage therapyIntensive care medicineViral loadDrugPharmacotherapyDrug resistance
MeSH terms
Drug Therapy, CombinationHumansHIV InfectionsAnti-HIV Agents
Citations
539
FWCI
65.57
field-weighted impact
References
107
Percentile
100%
vs. same field & year
Citations per year
Cited by
Adverse effects of reverse transcriptase inhibitors
AIDS · 1998 · 848 citations
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
AIDS · 2002 · 427 citations
First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response
The Journal of Infectious Diseases · 1998 · 638 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.